S295: CLINICAL RELEVANCE OF SPLEEN VOLUME AND PLATELET COUNT WITH BLEEDING EVENTS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY (ASMD)

• M. Fournier,
• J. Msihid,
• A. Willemze,
• F. Laredo,
• R. Pulikottil-Jacob

Affiliations

M. Fournier

1 Sanofi, Chilly-Mazarin, France

J. Msihid

1 Sanofi, Chilly-Mazarin, France

A. Willemze

2 Sanofi, Amsterdam, Netherlands

F. Laredo

3 Sanofi, São Paulo, Brazil

R. Pulikottil-Jacob

4 Rare Disease, Health Economics and Value Assessment, Sanofi, Berkshire, United Kingdom